# Exozymes Inc. (EXOZ)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $48M  
**Price:** $7.72 (-1.03%)

> Exozymes Inc. operates in the biotechnology sector with a focus on developing enzyme-based products for industrial applications. The primary function of Exozymes Inc. is to leverage advanced enzymatic solutions to enhance processes across various industries, including pharmaceuticals, agriculture, and biofuels. Through its innovative approach, the company aims to improve efficiency, reduce environmental impact, and provide sustainable alternatives to traditional chemical processes. Exozymes Inc. plays a key role in the market by offering customizable enzyme solutions that cater to specific industrial needs, thereby driving technological advancements and promoting cleaner manufacturing practices. Its presence underscores the importance of biotechnology in revolutionizing conventional methods and addressing global environmental challenges.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $70,069 | — | -$2M | -$2M | $-0.33 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2023 | $4M | $4M | -$384,319 | $66,533 | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$7M | $169,917 | -$7M |
| 2024 | -$9M | $396,451 | -$9M |
| 2023 | -$1M | $288,712 | -$1M |

Source: [CompaniesByCap](https://companiesbycap.com/company/EXOZ)